The main methods for preparing cephalosporins include chemical synthesis and enzymatic methods, as well as other methods such as gene-regulated biosynthesis. However, chemical synthesis remains the dominant method, with semi-synthetic methods based on major antibiotic nuclei and methods that produce cephalosporins from penicillin through oxidation, ring expansion, and rearrangement being widely used. The structural formula of cefotaxime hydrochloride is as follows: [Image of cefotaxime hydrochloride structure shown in Figure 1] Due to the chemical instability of the cephalosporin nucleus, the more reactions it participates in, the more difficult it is to control the quality of the final product. Therefore, according to literature reports, cefotaxime hydrochloride can be synthesized via the following synthetic route.
Route A: This route involves reacting the core of 7-amino-3-(1-methyl-1H-tetrazole-5-thiomethyl)cephalosporanic acid salt (7-ACA-MMT) with a 4-halo-2-methoxyimino-butyric acid derivative, followed by cyclization with sulfur to obtain the target product.
Figure 2 shows the synthetic route A for cefotaxime hydrochloride.
This route is cumbersome and has a very low yield. The main raw material, the 4-halo-2-methoxyimino-butyric acid derivative, is not readily available in large quantities on the market. Its activation must be carried out at low temperatures for a long time, which is time-consuming and energy-intensive. Furthermore, it involves numerous side reactions, resulting in unsatisfactory product yield and purity. Therefore, this route was abandoned.
Route B: This involves first synthesizing 7-[2-(2-amino-4-thiazolyl)-2(Z)-methoxyiminoacetic acid (ATMAA, part B, abbreviated as aminothiazolyl) and 7-aminocephalosporanic acid (part C, abbreviated as 7-ACA) to obtain 7-[2-(2-amino-4-thiazolyl)-2(Z)-methoxyiminoacetic acid]aminocephalosporanic acid (abbreviated as cephalothiazolyl), and then reacting it with 1-methyl-5-mercapto-1H-tetrazole to synthesize the target product, cefotaxime.
Figure 3 shows the synthetic route B for cefotaxime hydrochloride.
Experiments revealed that the product produced by the reaction of cefotaxime acid with 1-methyl-5-mercapto-1H-tetrazole (MMT) via this route was of poor quality and had a low yield. The main reason for this was believed to be the prolonged (3.5 h) immersion of the 7-ACA cephalosporin nucleus in aqueous solution at 55–60 °C, which partially destroyed the nucleus, darkened the system color, and resulted in a lower purity product, significantly increasing the difficulty of subsequent purification. Route C: This route involves synthesizing 7-aminocephalosporanic acid (7-ACA) with 1-methyl-5-mercapto-1H-tetrazole (MMT) to obtain 7-amino-3-(1-methyl-1H-tetrazole-5-thiomethyl)cephalosporanic acid salt (7-ACA-MMT), which is then condensed with 2-(2-amino-4-thiazolyl)-2(Z)-methoxyiminoacetic acid-2-benzothiazolyl thioester (MAEM, abbreviated as AE-active ester) to obtain the target compound, cefotaxime.
Figure 4 shows the synthetic route C for cefotaxime hydrochloride.
This route is simple to operate, and after experimental investigation, the yield and quality are relatively ideal, making it a suitable route for the synthesis of the target compound.
